Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$15,166,944
+$2,101,515 QoQ
Shares Held
79,986
+20.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#261
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allianz SE holds $193,228,091 across 11 Drug Manufacturers - General names. AZN ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
2,683,370 | $64,615,548 | |
| 2 | LLY |
ELI LILLY & Co
|
31,653 | $37,965,558 | |
| 3 | JNJ |
Johnson & Johnson
|
89,438 | $22,714,568 | |
| 4 | ABBV |
AbbVie Inc.
|
83,772 | $21,080,385 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
79,986 | $15,166,944 | |
| 6 | MRK |
Merck & Co., Inc.
|
112,208 | $14,418,728 | |
| 7 | AMGN |
Amgen Inc
|
31,246 | $11,314,800 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
94,851 | $5,465,313 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,166,944 | 79,986 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $13,065,429 | 66,248 | Shares | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||